Owen A. Warmuth

Owen A. Warmuth

Auto-generated profile, based on publicly available information

Owen A. Warmuth

University of Wisconsin-Madison, Department of Biochemistry (Madison, WI)

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2025 in Science Advances
Verified
Journal Article
Open access
SWSonglin Wang
Songlin Wang
TRThirupathi Ravula
Thirupathi Ravula
JSJohn A. Stringer
John A. Stringer
PGPeter L. Gor’kOv
Peter L. Gor’kOv
OWOwen A. Warmuth
Owen A. Warmuth
CRChad M. Rienstra
Chad M. Rienstra
Nuclear magnetic resonance (NMR) spectroscopy is a powerful technique with broad impact across the physical and life sciences, and ultrahigh field (UHF), gigahertz-class NMR spectrometers offer exceptional performance, including superior resolution and sensitivity. In solid-state NMR (SSNMR), resolution is primarily constrained by instrumentation rather than molecular tumbling, making it well suited for studying large and complex systems. To fully leverage UHF magnets for SSNMR, it is essential to eliminate line broadening arising from magnetic field drift and couplings among the nuclear spins. We address these challenges using external 2 H lock to compensate for the field drift and long-observation-window band-selective homonuclear decoupling to suppress 13 C homonuclear couplings. We achieve better than 0.2–parts per million resolution in proteins up to 144 kilodalton, enabling unique site resolution for more than 500 amide backbone pairs in two-dimensional experiments. This exceeds the resolution available from solution NMR for large biological molecules, greatly expanding the potential of gigahertz-class NMR for research in life sciences.

2 May 2025 in bioRxiv
Verified
Preprint
Open access
MMMoses H. Milchberg
Moses H. Milchberg
OWOwen A. Warmuth
Owen A. Warmuth
CBCollin G. Borcik
Collin G. Borcik
DDDhruva Dhavale
Dhruva Dhavale
EWElizabeth Wright
Elizabeth Wright
CRChad M. Rienstra
Chad M. Rienstra
The accumulation of Alpha-synuclein (Asyn) fibrils is the defining pathologic feature in Parkinson Disease (PD), Lewy Body Dementia (LBD), and Multiple System Atrophy (MSA). As such, the process of Asyn fibril formation has been an important research area and fibrils themselves have become attractive targets for disease diagnosis and therapeutic intervention. Due to the presence of mixed populations of fibrillar proteins associated with neurodegenerative diseases in brain tissue, high-resolution structures of Asyn fibrils are essential for the design of high-specificity imaging and therapeutic agents. Approximately one hundred high-resolution solid-state NMR (SSNMR) spectroscopy and cryo-electron microscopy (cryo-EM) structures of Asyn fibrils have been deposited to the Protein Databank (PDB); intriguingly there is significant polymorphism among them. Understanding the molecular makeup and characteristic features of each structural polymorph can determine conserved structural motifs which can be used as templates to design ligands with high specificity for clinical use. Utilizing standard alignment tools and density-based clustering approaches, we objectively classify fibril structures by tertiary structure type. We find that 81% of the structures cluster into two polymorph classes. Within each class, additional subtle variations are observed which position sidechains in specific, conserved orientations, well poised as druggable targets. Furthermore, we find that the conserved structural motifs associated with each class are found in all but one published Asyn fibril structure. We consider these classifications and conserved motifs in the context of disease-relevant fibril structures and offer a perspective on the utility of in vitro fibrils as substrates for drug development and models for disease pathogenesis.

10 January 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
DDDhruva Dhavale
Dhruva Dhavale
ABAlexander M. Barclay
Alexander M. Barclay
CBCollin G. Borcik
Collin G. Borcik
KBKatherine Basore
Katherine Basore
IGIsabelle R. Gordon
Isabelle R. Gordon
PKPaul T Kotzbauer
Paul T Kotzbauer
The defining feature of Parkinson disease (PD) and Lewy body dementia (LBD) is the accumulation of alpha-synuclein (Asyn) fibrils in Lewy bodies and Lewy neurites. We developed and validated a novel method to amplify Asyn fibrils extracted from LBD postmortem tissue samples and used solid state nuclear magnetic resonance (SSNMR) studies to determine atomic resolution structure. Amplified LBD Asyn fibrils comprise two protofilaments with pseudo-2 1 helical screw symmetry, very low twist and an interface formed by antiparallel beta strands of residues 85-93. The fold is highly similar to the fold determined by a recent cryo-electron microscopy study for a minority population of twisted single protofilament fibrils extracted from LBD tissue. These results expand the structural landscape of LBD Asyn fibrils and inform further studies of disease mechanisms, imaging agents and therapeutics targeting Asyn.

30 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
AHAshley B. Hiett-Borcik
Ashley B. Hiett-Borcik
BHBenjamin D. Harding
Benjamin D. Harding
MBMerissa Brousseau
Merissa Brousseau
OWOwen Warmuth
Owen Warmuth
CBCollin G. Borcik
Collin G. Borcik
KHKatherine A. Henzler-Wildman
Katherine A. Henzler-Wildman
The multidrug efflux pump EmrE is one of the smallest known active transporters and has become a model system for studying multidrug recognition and transport. While recent high-resolution structures have illuminated its dynamic substrate binding pocket, the conformations of its interhelical loops and C-terminal tail, regions critical for controlling proton coupling and gating, remain poorly characterized. Here, we report the high-resolution structure of protonated S64V EmrE determined using solution and solid-state NMR data. This new structural model shows the C-terminal tail occluding the open face of the transport pore, providing a structural basis for how EmrE minimizes proton leak in the absence of substrate. These findings support growing evidence that relatively simple model transporters must leverage an occluded state during alternating access to avoid physiologically unfavorable proton leak.

5 February 2026 in bioRxiv
Verified
Preprint
Open access
MMMoses H. Milchberg
Moses H. Milchberg
OWOwen A. Warmuth
Owen A. Warmuth
CBCollin G. Borcik
Collin G. Borcik
RHRuixian Han
Ruixian Han
BHBenjamin D. Harding
Benjamin D. Harding
CRChad Michael Rienstra
Chad Michael Rienstra
: The pathological hallmark of Parkinson Disease (PD) is the formation of the protein alpha-synuclein (Asyn) into β-sheet rich, self-templating fibrils in the brain. Since the first atomic structure of wild-type Asyn fibrils was determined nearly a decade ago, several other in vitro structures of hereditary mutant fibrils and structures derived from post-mortem diseased patient tissue have been determined by solid-state nuclear magnetic resonance (SSNMR) spectroscopy and cryo-electron microscopy. These structures have not only expanded the library of structures available for computational modeling of drug binding and therapeutics development but have also given unprecedented insight into the disease specificity and structural polymorphism of Asyn fibrils. Here, we report the high-resolution SSNMR structure of the A30P hereditary mutant Asyn fibril, associated with early-onset PD. Our structural model is calculated using several thousand distance restraints derived from one sample, primarily sourced through 3D 13C-13C-13C correlation experiments. The structure adopts a Greek key topology yet does not include the P30 mutation site within the fibril core. We also introduce a comprehensive method for the rapid comparison of SSNMR spectra between Asyn polymorphs of known structure and validate the A30P fold. Lastly, we find that the structure is highly similar to many other experimental structures of both in vitro and ex vivo Asyn fibrils, including those with other hereditary point mutations, suggesting a conserved accessible fold

6 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
CHColin A. Hemme
Colin A. Hemme
OWOwen A. Warmuth
Owen A. Warmuth
SWSonglin Wang
Songlin Wang
CWChristopher G. Williams
Christopher G. Williams
ATAlexander Thome
Alexander Thome
TGTimothy Grant
Timothy Grant
With recent advances in magic-angle spinning (MAS) solid-state NMR (SSNMR) resolution, precise spectral alignment has become a critical bottleneck in data processing workflows. While solution NMR employs deuterium lock systems, most SSNMR probes still lack this capability; though a lock corrects for magnet drift and instabilities, it is not alone sufficient to account for field gradients, sample temperature differences, and pulse sequence effects that can contribute to referencing errors among several data sets. These offsets become particularly problematic in the lengthy multidimensional experiments that provide the foundation for resonance assignment and structure determination procedures. Currently, researchers rely on manual alignment through visual peak inspection—a qualitative approach that often overemphasizes prominent, outlying peaks while overlooking subtle, global patterns. This subjective process becomes increasingly impractical for use cases with lower sensitivity, such as large proteins with thousands of peaks. To address these challenges, here we present Automated NMR Spectral Alignment ( ANSA ), a program that adapts cryo-electron microscopy motion correction principles to NMR spectroscopy. ANSA treats NMR spectra as images and applies cross-correlation functions to determine optimal alignment, improving cross-correlation scores from 0.33 to 1.00 in controlled tests and achieving 0.96 correlation in real-world applications with previously misaligned spectra. The algorithm successfully aligns spectra across varying experimental conditions, corrects shifts in long-duration experiments, and works with 2D and 3D datasets, with approaches that can be readily extended to additional dimensions. By eliminating human bias and providing objective, consistent spectral alignment, ANSA enhances scientific rigor, improves reproducibility between experiments, and enables automation of critical data processing steps. The software is freely available as an open-source tool, ready for integration into existing NMR workflows.